Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The potential of developing high hepatic clearance drugs via controlled release: Lessons from Kirchhoff's Laws

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.07.040Source: DataRank Database

The potential of developing high hepatic clearance drugs via controlled release: Lessons from Kirchhoff's Laws is a research paper published in Journal of Controlled Release (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.84)OA: hybridTopics (76)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Markus Ville Tiitto,Jasleen K. Sodhi ORCID,Leslie Z. Benet ORCID

Live enrichment

PubMed:39032574 PMC:PMC11731068 OpenAlex:https://openalex.org/W4400898906

NIDDK NIH HHS

Grant: P30 DK026743

NIGMS NIH HHS

Grant: T32 GM007546

National Institutes of Health

Grant: 2T32GM007546-49

Clinical Pharmacology, Drug Action and Pharmacogenetics

National Institutes of Health

Grant: 5P30DK026743-27

UCSF Liver Core Center

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.jconrel.2024.07.040

publisherhttps://doi.org/10.1016/j.jconrel.2024.07.040

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39032574

repositoryhttps://escholarship.org/uc/item/8cx5r7n3

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11731068

Fields of Study

Analytical Chemistry and ChromatographyDrug Solubulity and Delivery SystemsPharmacogenetics and Drug Metabolism0301 basic medicine03 medical and health sciences0302 clinical medicineHumansDelayed-Action PreparationsLiverMetabolic Clearance RatePharmaceutical PreparationsDrug Delivery SystemsModels, BiologicalDrug Development

MeSH Terms

Drug DevelopmentDelayed-Action PreparationsPharmaceutical PreparationsHumansLiverMetabolic Clearance RateModels, BiologicalDrug Delivery Systems

Keywords

PharmacokineticsDrugPharmacologyClearanceClearance rateDrug deliveryMetabolic clearance rateMedicineDosingDistribution (mathematics)Plasma clearanceChemistryMathematicsInternal medicineUrologyAbsorptionControlled releaseKirchhoff's LawsMetabolic Clearance Rate (mesh)Liver (mesh)Biomedical Engineering610Biotechnology (rcdc)Biological (mesh)Models, BiologicalDrug Development (mesh)ArticlePharmacology & Pharmacy (science-metrix)0903 Biomedical Engineering (for)Drug Delivery SystemsDrug Development5.1 Pharmaceuticals (hrcs-rac)Models6150904 Chemical Engineering (for)HumansPharmacology & Pharmacy32 Biomedical and Clinical Sciences (for-2020)3214 Pharmacology and Pharmaceutical Sciences (for-2020)Humans (mesh)Biomedical and Clinical Sciences1115 Pharmacology and Pharmaceutical Sciences (for)Pharmaceutical Preparations (mesh)Pharmacology and Pharmaceutical SciencesChemical EngineeringBiological4003 Biomedical engineering (for-2020)Drug Delivery Systems (mesh)LiverPharmaceutical Preparations5.1 PharmaceuticalsDelayed-Action PreparationsDelayed-Action Preparations (mesh)Biotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being